Regulation of Tumor and Metastasis Initiation by Chemokine Receptors

Anthony DiNatale1,2, Maria Sofia Castelli1,3, Bradley Nash1

  • 1Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, PA 19102, USA.

Journal of Cancer
|September 19, 2022
PubMed

Insights

Tumor-initiating cells (TICs) drive cancer growth and spread. Targeting specific chemokine receptors may disrupt the signaling pathways that maintain TICs, offering a novel therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Tumor-initiating cells (TICs) are crucial for tumor initiation, metastasis, and chemoresistance.
  • TICs possess stem-cell-like properties regulated by master transcription factors like OCT4, NANOG, and SOX2.
  • These factors are controlled by signaling pathways activated during cancer progression.

Purpose of the Study:

  • To review the transcription factors dictating the TIC phenotype.
  • To summarize signaling pathways involved in TIC master regulator expression.
  • To identify chemokine receptors upstream of TIC phenotype development.

Main Methods:

  • Literature review of studies on TICs, transcription factors, signaling pathways, and chemokine receptors.
  • Analysis of the interplay between chemokine receptor signaling and stemness pathways.
  • Focus on cell surface chemokine receptors as therapeutic targets.

Main Results:

  • Master regulator transcription factors (OCT4, NANOG, SOX2) define the TIC phenotype.
  • Multiple signaling pathways regulate the expression of these transcription factors.
  • Chemokine receptors activate these pathways, driving the TIC phenotype and offering a therapeutic target.

Conclusions:

  • Chemokine receptors are key drivers of the TIC phenotype by activating stemness pathways.
  • Targeting cell surface chemokine receptors can disrupt TIC signaling.
  • This presents a promising strategy for developing new cancer therapies.

Related Concept Videos

Chemotaxis and Direction of Cell Migration01:21

Chemotaxis and Direction of Cell Migration

Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon...
3.5K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.4K